{
 "drug": "Moxifloxacin Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "10/29/2025",
 "dayN": 300,
 "cat": "Anti-Infective",
 "companies": [
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "10/29/2025",
   "update_type": "New",
   "initial_posting_date": "10/29/2025",
   "package_ndc": "63323-850-74",
   "generic_name": "Moxifloxacin Injection",
   "contact_info": "888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA205572"
    ],
    "brand_name": [
     "MOXIFLOXACIN"
    ],
    "generic_name": [
     "MOXIFLOXACIN HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-850"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MOXIFLOXACIN HYDROCHLORIDE"
    ],
    "rxcui": [
     "351156"
    ],
    "spl_id": [
     "4070f637-059f-4e3d-8cf3-e5256a46ff3e"
    ],
    "spl_set_id": [
     "a4e28b09-714b-46e7-b4e6-0163cad78fc5"
    ],
    "package_ndc": [
     "63323-850-74",
     "63323-850-04"
    ],
    "unii": [
     "C53598599T"
    ]
   },
   "update_date": "10/29/2025",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Moxifloxacin, Injection, 400mg per 250mL (NDC 63323-850-74)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  }
 ]
}